TY - JOUR
T1 - Short-form Zarit Caregiver Burden Interviews were valid in advanced conditions
AU - Higginson, Irene J.
AU - Gao, Wei
AU - Jackson, Diana
AU - Murray, Joanna
AU - Harding, Richard
PY - 2010/5
Y1 - 2010/5
N2 - Objectives: To assess six short-form versions of Zarit Burden Interview (ZBI-12, ZBI-8, ZBI-7, ZBI-6, ZBI-4, and ZBI-1) among three caregiving populations.
Study Design and Setting: Secondary analysis of carers' surveys in advanced cancer (n = 105), dementia (n = 131), and acquired brain injury (n = 215). All completed demographic information and the ZBI-22 were used. Validity was assessed by Spearman correlations and internal consistency using Cronbach's alpha. Overall discrimination ability was evaluated using the area under the receiver operating characteristic curve (AUC).
Results: All short-form versions, except the ZBI-1 in advanced cancer (rho = 0.63), displayed good correlations (rho = 0.74-0.97) with the ZBI-22. Cronbach's alphas suggested high internal consistency (range: 0.69-0.89) even for the ZBI-4. Discriminative ability was good for all short forms (AUC range: 0.90-0.99); the best AUC was for ZBI-12 (0.99; 95% confidence interval [CIF 0.98-0.99) and the second best for ZBI-7 (0.98; 95% Cl: 0.96-0.98) and ZBI-6 (0.98; 95% Cl: 0.97-0.99).
Conclusions: All six short-form ZBI have very good validity, internal consistency, and discriminative ability. ZBI-12 is endorsed as the best short-form version; ZBI-7 and ZBI-6 show almost equal properties and are suitable when a fewer-question version is needed. ZBI-4 and ZBI-1 are suitable for screening, but ZBI-1 may be less valid in cancer. (C) 2010 Elsevier Inc. All rights reserved.
AB - Objectives: To assess six short-form versions of Zarit Burden Interview (ZBI-12, ZBI-8, ZBI-7, ZBI-6, ZBI-4, and ZBI-1) among three caregiving populations.
Study Design and Setting: Secondary analysis of carers' surveys in advanced cancer (n = 105), dementia (n = 131), and acquired brain injury (n = 215). All completed demographic information and the ZBI-22 were used. Validity was assessed by Spearman correlations and internal consistency using Cronbach's alpha. Overall discrimination ability was evaluated using the area under the receiver operating characteristic curve (AUC).
Results: All short-form versions, except the ZBI-1 in advanced cancer (rho = 0.63), displayed good correlations (rho = 0.74-0.97) with the ZBI-22. Cronbach's alphas suggested high internal consistency (range: 0.69-0.89) even for the ZBI-4. Discriminative ability was good for all short forms (AUC range: 0.90-0.99); the best AUC was for ZBI-12 (0.99; 95% confidence interval [CIF 0.98-0.99) and the second best for ZBI-7 (0.98; 95% Cl: 0.96-0.98) and ZBI-6 (0.98; 95% Cl: 0.97-0.99).
Conclusions: All six short-form ZBI have very good validity, internal consistency, and discriminative ability. ZBI-12 is endorsed as the best short-form version; ZBI-7 and ZBI-6 show almost equal properties and are suitable when a fewer-question version is needed. ZBI-4 and ZBI-1 are suitable for screening, but ZBI-1 may be less valid in cancer. (C) 2010 Elsevier Inc. All rights reserved.
U2 - 10.1016/j.jclinepi.2009.06.014
DO - 10.1016/j.jclinepi.2009.06.014
M3 - Article
VL - 63
SP - 535
EP - 542
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
IS - 5
ER -